FAVOR III E-J Trial – Enrollment completed

Congratulations to all the FAVOR III E-J sites across Europe for their dedicated efforts in enrolling 2000 patients for this very important trial! The 2000th patient was enrolled on July 21, 2023.
 
The FAVOR III E-J trial is a carefully designed and executed prospective, randomized, multi-center study comparing the Medis QFR® image-based coronary physiology solution applied in the on-line setting, versus the traditional wire-based FFR approach. It is the very first of ongoing non-inferiority trials that has completed its enrollment.
 
We are eagerly looking forward to the results of this exciting trial after the 1-year follow-up. Together with our users we continue our mission to drive medical innovation and strive for better healthcare for patients worldwide.
 
Once again, our sincere gratitude to all the FAVOR III E-J sites for all their efforts.